You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

~ Buy the TRIJARDY XR (empagliflozin; linagliptin; metformin hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

Suppliers and packages for tradename: TRIJARDY XR

✉ Email this page to a colleague

« Back to Dashboard

TRIJARDY XR

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Boehringer Ingelheim	TRIJARDY XR	empagliflozin; linagliptin; metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212614	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0380-13	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-13)	2020-04-23
Boehringer Ingelheim	TRIJARDY XR	empagliflozin; linagliptin; metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212614	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0380-68	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-68)	2020-04-23
Boehringer Ingelheim	TRIJARDY XR	empagliflozin; linagliptin; metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212614	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0385-77	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-77)	2020-04-23
Boehringer Ingelheim	TRIJARDY XR	empagliflozin; linagliptin; metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212614	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0385-86	180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86)	2020-04-23
Boehringer Ingelheim	TRIJARDY XR	empagliflozin; linagliptin; metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212614	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0385-88	1 BOTTLE in 1 CARTON (0597-0385-88) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE	2020-04-23
Boehringer Ingelheim	TRIJARDY XR	empagliflozin; linagliptin; metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212614	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0390-13	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13)	2020-04-23
Boehringer Ingelheim	TRIJARDY XR	empagliflozin; linagliptin; metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212614	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0390-31	1 BOTTLE in 1 CARTON (0597-0390-31) / 7 TABLET, EXTENDED RELEASE in 1 BOTTLE	2020-04-23
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.